Certain blood-glucose test strips called GDH-PQQ strips, maybe inaccurate when it comes to measuring blood sugar levels, leading to patients receiving inaccurate information that could then result in them acting inappropriately relating to giving insulin shots.
Submitted by Amy Tenderich
I am 6' 2" and was always around 170 lbs. Then when I was diagnosed with type 1 diabetes in 2005, I went down to 150 lbs. and have stayed around that area. I would like to be back around 170 but cannot get there for the life of me. I eat about 2-3 times more than the average person a day, and still cannot gain weight. I usually keep my blood sugar in a... read more
Submitted by John Crowley
I have high blood sugars in the morning (165 – 240) and also in the afternoon (260-350). I take 1000mg metformin twice daily. Is it time for insulin?
Submitted by John Crowley
A senator asking Supreme Court Sonia Sotomayor about her diabetes wouldn’t be out of line, an expert on the disease says.
Submitted by Amy Tenderich
A must-read for anyone using a Medtronic insulin pump.
Submitted by Amy Tenderich
The series of articles brings up all sorts of questions: Do other newer long-acting insulin analogs such as Levemir (insulin detemir) also share this association? If Lantus is associated with cancer, what kind of cancer? Does the administration of insulin cause a new cancer, or cause a pre-existing cancer to grow faster than if there had been no insulin therapy? None of these questions are answered in the studies that are published here.
Submitted by Avera
The buzz on the Internet this weekend is the news that insulin glargine (Lantus) might increase cancer rates. Needless to say, this is very upsetting news to a lot of people, although Lantus has been linked with cancer in the past.
Submitted by Avera
Last week, a team of eight cyclists completed the coast-to-coast bike marathon called the Race Across America in record time. It was quite an achievement under any circumstances, but what made it extraordinary was something all eight of them had in common: Type 1 diabetes.
Submitted by Amy Tenderich
For more than a decade, MannKind Corp. of Valencia, Calif., has sunk about $1 billion into developing a fast-acting inhaled insulin, touting it as easier to take than frequent injections and medically superior to traditional medicines for controlling blood sugar.
Submitted by Amy Tenderich
The real answer to this question is “who knows, it totally depends”, but I will try and give you a baseline to work from. The UKPDS (United Kingdom Prospective Diabetes Study) indicates that the average weight gain for those new to insulin therapy is about 9 pounds. If your blood sugar has been running quite high (high 200’s, 300’s, a HbA1c greater than 9.5) for a couple of months, your body will be dehydrated and... read more
Submitted by John Crowley